A Collaborative Framework to Enhance Clinical Trial Participation and Health Equity in Sulawesi Island, Indonesia
Abstract
Introduction: In this study, we aimed to develop and evaluate a collaborative framework for integrating clinical trials into primary health care within the context of addressing health disparities in Sulawesi Island, Indonesia. With notable regional disparities in health service utilization and participation in clinical trials reported in the 2018 Indonesian Basic Health Survey, our objective was to bridge gaps in clinical trial access and improve health outcomes in underserved areas.
Methods: This quasi-experimental post-test control group study involved the implementation of a collaborative framework conducted across primary health care settings in Sulawesi over a six-month period. A total of 200 participants were enrolled, and data were collected through electronic health records (EHRs), surveys, and interviews. Ethical approval was obtained from the relevant ethics committee, and participants provided written informed consent.
Results: The primary outcome of the study was a significant increase in clinical trial participation, with rates rising from 25% to 60% in the intervention group, compared to 20% to 30% in the control group. Additionally, health outcomes improved, including reductions in average blood pressure (140/90 mmHg to 130/85 mmHg) and blood glucose levels (160 mg/dL to 140 mg/dL). Statistical analyses revealed a p-value of <0.05 for these changes. Key factors contributing to these results included training on digital health technologies and integration of trial data into EHRs.
Conclusion: In conclusion, our study contributes to the understanding of health equity by demonstrating the effectiveness of a localized collaborative framework in improving clinical trial participation and health outcomes. This research provides insights into the importance of tailored interventions, digital health infrastructure, and training programs in addressing disparities in underserved regions. Future studies should address the scalability and long-term impact of this framework, ultimately advancing health equity in Indonesia.
References
2. INA-RESPOND. (2023). INA-RESPOND: a multi-centre clinical research network in Indonesia. Health Research Policy and Systems, 21(1), pp. 45-56. doi: 10.1186/s12961-023-00987-7.
3. Claramita, M., Hilman, O., Ekawati, F. M., Syah, N. A., & Arisanti, N. (2023). Indonesia: a primary health care case study in the context of the COVID-19 pandemic. World Health Organization. Tersedia di:https://ahpsr.who.int/publications/i/item/indonesia-a-primary-health-care-case-study-in-context-of-the-covid-19-pandemic.
4. Purkayastha, S. (2021). Electronic Health Records: An Overview. Springer, Vol. 1, pp. 120-135. doi: 10.1007/978-3-030-12345-6.
5. Husain, M. T., Mahmud, S., & Chowdhury, N. (2021). The impact of healthcare facility distribution on service delivery in rural areas: A systematic review. Health Policy and Planning, 36(4), 423-437.
6. Kurniawan, Y., & Hadi, S. (2023). The role of facility availability and distribution in health service utilization: A study from Indonesia. Asian Journal of Public Health, 14(1), 32-47.
7. Sahakian, J., Lee, C., & Zulkifli, M. (2022). Disparities in health service participation: Implications for policy and practice. International Journal of Health Services, 52(3), 378-392.
8. Hasan, A., Rahman, M. M., & Khatun, M. R. (2023). Regional disparities in healthcare access and quality: Evidence from Indonesia. Journal of Regional Health Studies, 16(2), 105-121.
9. Smith, J. L., Patel, R., & Kumar, S. (2021). Enhancing participant engagement in clinical trials through targeted interventions. Clinical Trials Journal, 18(4), 295-310.
10. Nguyen, T. H., Zhang, Y., & Lee, A. (2023). Community-based interventions to enhance clinical trial participation: A systematic review. Journal of Clinical Research, 29(3), 312-326.
11. Roberts, C. R., Thompson, M., & Williams, R. (2024). Improving clinical trial recruitment and retention: Insights from recent interventions. Journal of Health Research, 25(1), 45-59.
12. Wong, M. C., Leung, K. S., & Tsang, C. H. (2022). The role of intervention strategies in increasing clinical trial enrollment: Evidence from a multi-site study. Health Services Research, 57(2), 223-238.
13. Magnuson, A., Lester, S., & Johnson, A. (2021). Broadening trial eligibility criteria to enhance trial access and ensure diverse representation. Journal of Clinical Oncology, 39(6), pp. 120-128. doi: 10.1200/JCO.20.02521.
14. Baba, Y. (2023). Patient and public involvement (PPI) in the development of trial tools: Essential for patient participation. Patient-Centered Research Journal, 10(2), pp. 95-105. doi: 10.1177/23333936211023632.
15. Sun, T. (2023). Psychological status and participation in clinical trials: A nuanced perspective. Psychological Science, 34(1), pp. 102-112. doi: 10.1177/09567976211038085.
16. Ainsworth, B. E., Rhyner, D., & Walker, S. (2022). Community-based interventions for hypertension and diabetes management: A systematic review and meta-analysis. Journal of Preventive Medicine, 29(1), 45-58.
17. Johnson, M. T., Nguyen, H. T., & Davis, K. (2023). Effectiveness of structured interventions in managing blood pressure and blood glucose levels: Evidence from recent trials. Clinical Trials Journal, 19(2), 211-226.
18. Lee, H. S., Smith, R. J., & Brown, C. (2024). Impact of lifestyle modification programs on hypertension and diabetes control: A comparative study. International Journal of Health Promotion and Education, 32(4), 345-360.
19. Roennow, A., et al. (2020). Collaborative frameworks in clinical trials: Addressing the needs of patients and caregivers through transparent collaborations. Clinical Trials Journal, 17(3), pp. 212-230. doi: 10.1177/1740774519874876.
20. Duma, N., et al. (2018). Increasing access to trials for minority and elderly patients: Challenges and solutions. Cancer Treatment Reviews, 70, pp. 77-86. doi: 10.1016/j.ctrv.2018.08.003.
21. Uveges, J., et al. (2018). Utilizing patient navigators to address individual needs and concerns of participants in clinical trials. Journal of Clinical Trials, 26(4), pp. 375-382. doi: 10.1016/j.jct.2018.05.002.
22. Wulandari, R., Dini, S., & Rahmawati, F. (2024). Comparative effectiveness of health interventions in clinical trials: A meta-analysis. Health Services Research, 58(1), 89-102.
23. Heynemann, N., et al. (2023). Therapeutic misconception and challenges to consent: Implications for patient decisions in clinical trials. Journal of Medical Ethics, 49(4), pp. 255-263. doi: 10.1136/medethics-2022-108221.
24. Srinivasan, S., et al. (2022). Cost-effectiveness of collaborative care models for treating depression in primary care. Journal of Affective Disorders, 298, pp. 204-213. doi: 10.1016/j.jad.2021.10.003.
25. Capdevila, J., et al. (2019). Cost savings in clinical trials: The role of free drug supplies by sponsors. Clinical Trials Review, 35(5), pp. 412-419. doi: 10.1016/j.ctr.2019.06.011.
26. Millar, M. M., et al. (2022). Enhancing provider involvement in clinical trials: Overcoming barriers through clinic-level interventions. Health Services Research, 57(2), pp. 654-670. doi: 10.1111/1475-6773.13821.
27. Schwarz, M., et al. (2021). The Hawthorne effect in clinical trials: Evidence from patient care within trials. Journal of Clinical Epidemiology, 134, pp. 26-34. doi: 10.1016/j.jclinepi.2021.01.013.
Copyright (c) 2025 Journal of Public Health and Pharmacy

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.